These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Bone mineral density in children with myelomeningocele. Quan A, Adams R, Ekmark E, Baum M. Pediatrics; 1998 Sep; 102(3):E34. PubMed ID: 9724682 [Abstract] [Full Text] [Related]
3. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V, Torregrosa V. Nefrologia; 2008 Sep; 28 Suppl 3():67-78. PubMed ID: 19018742 [Abstract] [Full Text] [Related]
4. Bone mineral density in children with myelomeningocele: effect of hydrochlorothiazide. Quan A, Adams R, Ekmark E, Baum M. Pediatr Nephrol; 2003 Sep; 18(9):929-33. PubMed ID: 12883972 [Abstract] [Full Text] [Related]
5. The role of vitamin D replacement therapy in serum FGF23 concentration in children with myelomeningocele compared with healthy children - a preliminary study. Bagińska J, Liszewska A, Korzeniecka-Kozerska A. J Pediatr Endocrinol Metab; 2019 Nov 26; 32(11):1259-1264. PubMed ID: 31465293 [Abstract] [Full Text] [Related]
6. Physical activity is associated with risk factors for chronic disease across adult women's life cycle. Woolf K, Reese CE, Mason MP, Beaird LC, Tudor-Locke C, Vaughan LA. J Am Diet Assoc; 2008 Jun 26; 108(6):948-59. PubMed ID: 18502225 [Abstract] [Full Text] [Related]
10. Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia. Terzi R, Dindar S, Terzi H, Demirtaş Ö. Metab Syndr Relat Disord; 2015 Mar 26; 13(2):78-83. PubMed ID: 25470355 [Abstract] [Full Text] [Related]
11. Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment. de Lind van Wijngaarden RF, Cianflone K, Gao Y, Leunissen RW, Hokken-Koelega AC. J Clin Endocrinol Metab; 2010 Apr 26; 95(4):1758-66. PubMed ID: 20173020 [Abstract] [Full Text] [Related]
13. Bone mineral density in children with myelomeningocele. Apkon SD, Fenton L, Coll JR. Dev Med Child Neurol; 2009 Jan 26; 51(1):63-7. PubMed ID: 18811711 [Abstract] [Full Text] [Related]
14. Relationship of Bone Metabolism Biomarkers and Periodontal Disease: The Osteoporotic Fractures in Men (MrOS) Study. Schulze-Späte U, Turner R, Wang Y, Chao R, Schulze PC, Phipps K, Orwoll E, Dam TT. J Clin Endocrinol Metab; 2015 Jun 26; 100(6):2425-33. PubMed ID: 25856210 [Abstract] [Full Text] [Related]
15. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. Link K, Moëll C, Garwicz S, Cavallin-Ståhl E, Björk J, Thilén U, Ahrén B, Erfurth EM. J Clin Endocrinol Metab; 2004 Oct 26; 89(10):5003-12. PubMed ID: 15472198 [Abstract] [Full Text] [Related]
16. Serum concentration of adipocytokines in prepubertal vegetarian and omnivorous children. Ambroszkiewicz J, Klemarczyk W, Gajewska J, Chełchowska M, Rowicka G, Ołtarzewski M, Laskowska-Klita T. Med Wieku Rozwoj; 2011 Oct 26; 15(3):326-34. PubMed ID: 22006488 [Abstract] [Full Text] [Related]
18. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. Salusky IB, Goodman WG, Sahney S, Gales B, Perilloux A, Wang HJ, Elashoff RM, Jüppner H. J Am Soc Nephrol; 2005 Aug 26; 16(8):2501-8. PubMed ID: 15944337 [Abstract] [Full Text] [Related]
19. Osteopenia and vitamin D deficiency in children with sickle cell disease. Chapelon E, Garabedian M, Brousse V, Souberbielle JC, Bresson JL, de Montalembert M. Eur J Haematol; 2009 Dec 01; 83(6):572-8. PubMed ID: 19682065 [Abstract] [Full Text] [Related]
20. Markers of bone metabolism, serum leptin levels and bone mineral density in preterm babies. Veselá PK, Kaniok R, Bayer M. J Pediatr Endocrinol Metab; 2016 Jan 01; 29(1):27-32. PubMed ID: 26181043 [Abstract] [Full Text] [Related] Page: [Next] [New Search]